A Multi-Center, Single Arm, Phase II Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer: HCRN GI14-186
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Sep 2017
At a glance
- Drugs Pembrolizumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 05 Sep 2017 Planned End Date changed from 1 Sep 2018 to 1 Apr 2018.
- 05 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Apr 2018.
- 02 Jun 2017 Preliminary results (data cut-off date: 29 Dec 2016), presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History